Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 4968
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68698
Here is a computerized ANALISIS of IPIX's
(1)
NotRichYet2
02/24/2021 8:27:13 AM
68696
Why is the phII trial not on clinicaltrials . gov
kerdom
02/24/2021 8:14:44 AM
68695
Awesome post Mo! I see it playing out pretty much
(5)
Ultimate
02/24/2021 7:31:35 AM
68693
My opinion on the number of B-CV19 trials is as
(20)
Mo
02/24/2021 1:11:57 AM
68692
I agree that Leo has missed a few PR
(1)
thefamilyman
02/24/2021 12:57:59 AM
68691
Leo put out quite a few PRs last year. Many some
(2)
Commando911
02/23/2021 11:47:56 PM
68690
Thank-you Pete, as usual a killer
angeli
02/23/2021 10:47:57 PM
68688
My take on "the market" is that retail are pawns
(11)
petemantx
02/23/2021 7:10:01 PM
68686
Speculation: I am also intrigued by the word
(4)
doubleJ23
02/23/2021 1:23:51 PM
68685
Ive been checking that site regularly.
Patchesohoulihan
02/23/2021 11:21:13 AM
68682
"it wont be long before we hear something."
(7)
farrell
02/23/2021 10:54:06 AM
68681
Don't get all hung up trying to parse language.
(4)
Drano
02/23/2021 10:23:05 AM
68680
Like I mentioned before, I also want additional
(6)
Ultimate
02/23/2021 10:10:32 AM
68678
Hi all, I'm trying to do some DD and see if there
(2)
doubleJ23
02/23/2021 9:46:24 AM
68675
A good and respected friend sent me this note
(10)
petemantx
02/22/2021 8:19:20 PM
68674
My take on todays events and 10-Q filing is
(13)
Mo
02/22/2021 5:47:17 PM
68673
I think the FDA is going to be trying very hard
(5)
Drano
02/22/2021 4:42:33 PM
68672
Just saw Fauci giving an update with a lot of
(4)
Chemdeps
02/22/2021 4:03:31 PM
68671
With the amount of people needed to fill the 120
(2)
petemantx
02/22/2021 3:56:07 PM
68670
Thats exactly as I see it. We are out of 1st
(2)
Ultimate
02/22/2021 3:00:50 PM
68669
Last week there was a document that showed 17, so
Drano
02/22/2021 2:48:13 PM
68668
Drano......I agree that common sense would tell
(1)
falcon74
02/22/2021 2:10:23 PM
68667
There are 17 clinical trial sites in Russia. I
(1)
Drano
02/22/2021 1:38:59 PM
68666
Chem---- I completely agree with your
(5)
falcon74
02/22/2021 1:04:10 PM
68665
I thought the statement that the phase II trials
(3)
Chemdeps
02/22/2021 12:52:08 PM
68664
Pete From the AS agreement. (i) Development
(3)
bettingbig
02/22/2021 12:18:54 PM
68663
Here's a list of "highlights" from the 10Q that I
(6)
Drano
02/22/2021 12:02:10 PM
68661
Is a successful P1 by AS considered a milestone
(1)
petemantx
02/22/2021 11:50:58 AM
68659
A little something MORE to look forward to.
(4)
NotRichYet2
02/22/2021 11:45:20 AM
68658
Excellent news! I thought covid impacted the
(7)
Ultimate
02/22/2021 11:44:47 AM
68657
"The Company is collaborating with a Regional
(10)
Drano
02/22/2021 11:44:07 AM
68656
10Q great news: " In January 2021, Alfasigma
(10)
Drano
02/22/2021 11:41:44 AM
68654
A phase2/3 or 3 wouldnt be possible if there
(2)
Ultimate
02/22/2021 11:19:04 AM
68651
Perhaps they are testing for other viruses also.
Fit007
02/22/2021 10:02:20 AM
68643
Maybe a ph3 with EUA in Russia. One can wonder.
(1)
zdubble17
02/22/2021 9:34:35 AM
68641
Thanks. That's one hell of an extension to end
(1)
crashco
02/22/2021 9:28:25 AM
68640
https://clinline.ru/reestr-klinicheskih-issledova
zdubble17
02/22/2021 9:26:02 AM
68638
I believe the trial has been extended
(1)
zdubble17
02/22/2021 9:24:57 AM
68634
I have been stressing on other sites that
(7)
petemantx
02/21/2021 8:02:20 PM
68633
24 days since our last press release. In a trial
(6)
Ultimate
02/21/2021 7:20:20 PM
68632
Article talking about investing in vaccines and
pizza
02/21/2021 7:01:04 PM
68631
Many past trials have shown the safety of
(8)
petemantx
02/21/2021 12:11:38 PM
68630
In my opinion,I am looking at the "developments"
(11)
Kelt
02/21/2021 11:27:07 AM
68629
https://pubmed.ncbi.nlm.nih.gov/33572467/ Dated
(1)
stocker11
02/21/2021 10:22:04 AM
68628
https://www.nytimes.com/2021/02/19/opinion/covid-
(3)
crashco
02/21/2021 7:44:43 AM
68627
Same. Most here know why I invested in 2012. So I
(3)
Commando911
02/20/2021 10:26:01 PM
68626
The link to the entire article on MicrocapDaily:
(9)
someconcerns
02/20/2021 12:24:00 PM
68625
Yes......another outstanding post by Pete!!! I
(8)
falcon74
02/20/2021 11:54:58 AM
68624
Thank you for that well thought out and inspiring
(8)
Ultimate
02/20/2021 11:38:19 AM
68623
Post I made this AM in regards to a good write up
(13)
petemantx
02/20/2021 10:22:26 AM
Newer
Older
Recent Articles
Valour's Revolutionary Dogecoin ETP Launches in the Nordics
SLANG Worldwide Inc. Files for Bankruptcy: Key Developments
MediWound Achieves Key Milestones in Third Quarter 2024
Calian Group Achieves Unprecedented Success in FY24 Results
DICK'S Sporting Goods Achieves Remarkable Third Quarter Growth
NG Energy Reports Impressive Growth in Q3 Financials
Analog Devices Achieves Strong Growth in Fourth Quarter
Amgen's MariTide Shows Potential in Treating Obesity Effectively
LASE Holdings: Transforming Laser Systems for Future Growth
Commercial Aircraft Manufacturing Growth Forecast Soars to $565 Billion
ScottsMiracle-Gro's Leadership Restructure to Enhance Growth
iTeos Therapeutics' Upcoming Conferences: Key Highlights for Investors
ECARX Shines at National Quality Conference, Showcases AI Innovation
Century Therapeutics to Showcase Innovations at Healthcare Event
Tonix Pharmaceuticals Highlights Upcoming Investor Conference Participation
Exploring OKYO Pharma's Role at the Upcoming BTIG Conference
Keeper Security Partners with Sherweb to Enhance Cyber Defense
NVIDIA Experiences 4.2% Drop Amid Strategic Call Option Sales
SpringWorks Therapeutics Announces Participation in Health Conference
Dick's Sporting Goods Raises Sales Outlook and Beats Q3 Estimates
Analog Devices Sees Positive Stock Movement Following Earnings
Eco Wave Power Collaborates to Launch Groundbreaking Wave Energy Plant
Nkarta Showcases Innovations at Upcoming Investor Conference
Understanding the Intricacies of MicroStrategy's Options Pricing
The Joint Corp. Enhances Engagement at Upcoming Investment Event
International Paper Looks to Expand with DS Smith Acquisition
Elon Musk vs. Neil deGrasse Tyson: A Debate on Mars Exploration
Novo Nordisk Shares Climb on New Obesity Care Coverage Proposal
Enwell Energy Restarts Operations in Ukraine's Fields
Thomas Belcher Takes on Senior Sales Role at Capital Square
Shareholder Approval for SLF Realisation Fund's Delisting
NexLiving Communities Achieves Record Growth and Dividends
Frasers Group Expands Reach with Holdsport Acquisition
Axsome Therapeutics' AXS-12: A New Hope for Narcolepsy
Leadership Overhaul at ScottsMiracle-Gro: New Directions Ahead
KalVista Pharmaceuticals Strengthens Board with New Appointment
Sarepta Therapeutics Expands Offerings with Licensing Deal
European Central Bank Faces Challenges Amid Weak Growth Signs
UK Retailers Face New Challenges Amid Falling Confidence Levels
JPMorgan Upgrades Enagás: A Positive Shift for Investors
Burlington Stores Faces Challenges Amid Missed Q4 Expectations
Analog Devices Reports Strong Q4 Results with Upbeat Guidance
Kohl's Adjusts Sales Expectations Ahead of Holiday Shopping
Kohl's Faces Challenges as Third-Quarter Results Disappoint
Best Buy Lowers Profit and Sales Outlook Amid Consumer Caution
Economic Concerns Weigh on Gold and Australian Dollar Trends
Exploring the Impact of Autonomous Vehicles on Key Stocks
Market Outlook: Stocks and AI Trends Amid Tariff Concerns
Qualcomm's Acquisition Hopes for Intel Diminish Amid Challenges
Canada Nickel Reaches Key Milestone in Impact Statement Process